ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Beyond CD30: Dual-Targeting of Malignant and Regulatory T Cells by Brentuximab Vedotin Remodels the Lymphoma Microenvironment and Overcomes Resistance via BCL2 Inhibition in Mycosis Fungoides.

Yi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.